eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

A.Menarini Pharma U.K. S.R.L.
Menarini House, Mercury Park, Wycombe Lane, Wooburn Green, Buckinghamshire, HP10 0HH
Telephone: +44 (0) 1628 856400
Fax: +44 (0) 1628 856402
Medical Information Direct Line: 0800 085 8678
Medical Information e-mail: menarini@medinformation.co.uk
Out of Hours contact: menarini@medinformation.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 24/01/2012
PIL Nebilet 5mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
Updated on 24/06/2011 and displayed until 24/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 20/05/2011 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to drug interactions
Updated on 10/07/2008 and displayed until 20/05/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 05/06/2008 and displayed until 10/07/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 13/08/2007 and displayed until 05/06/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 03/04/2006 and displayed until 13/08/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 07/02/2006 and displayed until 03/04/2006
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to dosage and administration
Updated on 17/04/2003 and displayed until 07/02/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  nebivolol hydrochloride